SPECTRIX THERAPEUTICS Trademark

Trademark Overview

On Wednesday, May 11, 2016, a trademark application was filed for SPECTRIX THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SPECTRIX THERAPEUTICS trademark a serial number of 87033626. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 9, 2020. This trademark is owned by Spectrix Therapeutics, LLC. The SPECTRIX THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the metabolic system, the respiratory system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, psychiatric and immune system related diseases and disorders; Drug delivery agents in the form of solid orals, oral liquids or other oral formulations that provide controlled release of the active ingredients for a wide variety of pharmaceuticals
spectrix therapeutics

General Information

Serial Number87033626
Word MarkSPECTRIX THERAPEUTICS
Filing DateWednesday, May 11, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 9, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 13, 2016

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the metabolic system, the respiratory system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, psychiatric and immune system related diseases and disorders; Drug delivery agents in the form of solid orals, oral liquids or other oral formulations that provide controlled release of the active ingredients for a wide variety of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 16, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSpectrix Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSouthlake, TX 76092
Party NameSpectrix Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSouthlake, TX 76092

Trademark Events

Event DateEvent Description
Monday, March 9, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 9, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 30, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 29, 2019EXTENSION 5 GRANTED
Wednesday, July 24, 2019EXTENSION 5 FILED
Monday, July 29, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 24, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 24, 2019TEAS EXTENSION RECEIVED
Wednesday, February 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 4, 2019EXTENSION 4 GRANTED
Monday, February 4, 2019EXTENSION 4 FILED
Monday, February 4, 2019TEAS EXTENSION RECEIVED
Thursday, August 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 31, 2018EXTENSION 3 GRANTED
Tuesday, July 31, 2018EXTENSION 3 FILED
Tuesday, July 31, 2018TEAS EXTENSION RECEIVED
Saturday, January 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 25, 2018EXTENSION 2 GRANTED
Thursday, January 25, 2018EXTENSION 2 FILED
Thursday, January 25, 2018TEAS EXTENSION RECEIVED
Saturday, August 5, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 3, 2017EXTENSION 1 GRANTED
Thursday, August 3, 2017EXTENSION 1 FILED
Thursday, August 3, 2017TEAS EXTENSION RECEIVED
Tuesday, February 7, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 13, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 23, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, October 29, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 27, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 27, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 27, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 19, 2016NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, August 19, 2016EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, August 19, 2016COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Friday, August 19, 2016EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Friday, August 19, 2016ASSIGNED TO EXAMINER
Monday, May 16, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 14, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics spectrix system preparations immune metabolic pharmaceutical disorders oral treatment formulations provide